4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-188869
Chief Business Officer sold 2,326 shares at $71.27 ($165,774)
- Chief Business Officer gave up 2,674 shares (to pay taxes)
- Chief Business Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Robb Gary Charles · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-22 | Exercise or conversion : show line 1 in the form | +5,000 | $3.88 | $19,400 | 18,364 | D |
| 2025-08-22 | Sale : show line 2 in the form | −2,326 | $71.27 | $165,774 | 16,038 | D |
| 2025-08-22 | Shares withheld for taxes : show line 3 in the form | −2,674 | $71.17 | $190,309 | 13,364 | D |
| Open-market sales · 2,326 sh · avg $71.27 · $165,774 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-22 | Exercise or conversion : show line 4 in the form Stock option (right to buy) | −5,000 | 145,000 | D |
Loading xslF345X05/ownership.xml…